Keyphrases
Polymorphism
100%
Pancreatic Cancer Cells
75%
Platinum-based Chemotherapy
61%
Non-small Cell Lung Cancer Patients
61%
Non-smokers
51%
Signaling Pathway
45%
Genotype
45%
Gene Polymorphism
43%
Pharmacokinetics
41%
Oxythiamine
41%
Type 2 Diabetic Patients
41%
China
41%
Pioglitazone
41%
Indole-3-butyric Acid
41%
Amino Acids
34%
Protein Expression
33%
Lung Cancer Patients
33%
Smokers
32%
Quantitative Proteomics
30%
Metabolic Pathway
30%
Oxidative Damage
29%
Protein Synthesis
29%
Let-7 microRNA
28%
Pancreatic Cancer
27%
Induced Toxicity
27%
Odds Ratio
26%
Cigarette Smokers
25%
Breast Cancer
25%
Signaling Molecules
25%
Drug Resistance
24%
Cisplatin-induced
24%
Auxin
24%
Type 2 Diabetes Mellitus (T2DM)
24%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
23%
Severe Toxicity
23%
Human Urine
22%
MIA PaCa-2 Cells
22%
Plasma Indices
20%
EIF3
20%
Meta-analysis
20%
RNA-binding Protein
20%
Bone Marrow Cells
20%
Cytochrome P450 3A (CYP3A)
20%
S100A9
20%
S100A8
20%
Glycogen Phosphorylation
20%
Bisphosphonates
20%
Cell Confluence
20%
Estrogen Receptor
20%
Amino Acid Labeling
20%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
74%
Amino Acids
51%
Cuniculidae
46%
Blood Plasma
44%
Gene Polymorphism
43%
Genotyping
41%
Signal Transduction
41%
Pioglitazone
41%
MicroRNA
41%
Proteome
41%
Estrogen Receptor
41%
Messenger RNA
36%
Quantitative Proteomics
36%
Metabolic Pathway
30%
Protein Biosynthesis
30%
Protein Expression
26%
Drug Resistance
25%
Glucose Blood Level
24%
Mass Spectrometry
24%
Genetic Polymorphism
20%
Protein Phosphorylation
20%
Binding Protein
20%
Haplotype
20%
Rigidity
20%
GSTP1
20%
Cisplatin
20%
down Regulation
20%
Stem Cell
20%
Pharmacogenetics
20%
Transport Protein
20%
Lipoprotein Receptor-Related Protein
20%
Peroxisome Proliferator-Activated Receptor
20%
Insulin-Like Growth Factor 2
20%
Ciclosporin
20%
Adipocyte
20%
DNA Repair
20%
Estrogen Receptor Alpha
20%
Cathepsin K
20%
LDL Receptor
20%
CYP3A
20%
Ubiquitin
20%
Protein Tyrosine Phosphatase
20%
Mitochondrial Membrane Transport Protein
20%
Pharmacokinetics
20%
Heme Oxygenase
20%
Carrier Protein
20%
Proteomics
19%
Cell Culture
18%
P Glycoprotein 1
16%
Osteoblast
15%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
45%
Pancreas Cancer
41%
Non Small Cell Lung Cancer
41%
Oxythiamine
33%
Malignant Neoplasm
26%
Chemotherapy
24%
Cisplatin
24%
Nitrogen 15
24%
Tobacco-Specific Nitrosamines
20%
Initiation Factor 3
20%
CYP3A
20%
Bisphosphonic Acid Derivative
20%
Acetylcysteine
20%
Ciclosporin
20%
Quinone Derivative
20%
Carrier Protein
20%
microRNA
20%
Estrogen Receptor Positive Breast Cancer
20%
Crotonaldehyde
20%
Low Density Lipoprotein Receptor Related Protein 5
20%
Adrenergic Receptor
20%
Bortezomib
20%
Ginkgo Biloba Extract
20%
Phenanthrene
20%
NNK
20%
1 Aminocyclopropanecarboxylic Acid
20%
Lipoprotein Receptor
20%
Ethylene
20%
Auxin
20%
Atorvastatin
20%
Amino Acid
20%
Multiple Myeloma
20%
Estrogen Receptor Alpha
20%
Hyperuricemia
20%
Cathepsin K
20%
Cuniculidae
19%
Polycyclic Aromatic Hydrocarbon
18%
Indolebutyric Acid
17%
Biological Marker
17%
Multidrug Resistance Protein 1
16%
Calcium Carbonate
15%
Thiosulfate
14%
Clofibric Acid
14%
Uric Acid
12%
Cell Culture
12%
Indoleacetic Acid
11%
Lung Cancer
11%
Calcium Supplement
10%
N-Nitrosonornicotine
10%
Breast Cancer
9%
